Short Interest in ReWalk Robotics Ltd. (NASDAQ:LFWD) Grows By 21.4%

ReWalk Robotics Ltd. (NASDAQ:LFWD) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 222,600 shares, an increase of 21.4% from the December 15th total of 183,400 shares. Currently, 3.0% of the shares of the company are sold short. Based on an average trading volume of 214,800 shares, the days-to-cover ratio is presently 1.0 days.

Insider Buying and Selling at ReWalk Robotics

In other ReWalk Robotics news, Director Michael Swinford purchased 16,471 shares of the stock in a transaction dated Wednesday, November 20th. The shares were bought at an average cost of $1.84 per share, with a total value of $30,306.64. Following the completion of the acquisition, the director now owns 26,511 shares of the company’s stock, valued at approximately $48,780.24. This trade represents a 164.05 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Global Fund Lp Lind II sold 381,676 shares of ReWalk Robotics stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the sale, the insider now owns 1,049,430 shares in the company, valued at approximately $3,526,084.80. This represents a 26.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have acquired 61,000 shares of company stock valued at $115,279 in the last quarter. Corporate insiders own 2.50% of the company’s stock.

Institutional Trading of ReWalk Robotics

A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP purchased a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned approximately 0.16% of ReWalk Robotics as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 26.76% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reiterated a “buy” rating and set a $13.00 price objective on shares of ReWalk Robotics in a research note on Wednesday, November 13th.

ReWalk Robotics Price Performance

Shares of LFWD traded down $0.17 during midday trading on Friday, reaching $1.64. The stock had a trading volume of 397,626 shares, compared to its average volume of 1,101,389. The company has a market capitalization of $14.45 million, a P/E ratio of -0.66 and a beta of 2.08. The firm’s 50 day moving average price is $1.88 and its 200-day moving average price is $2.80. ReWalk Robotics has a 52 week low of $1.41 and a 52 week high of $7.84.

ReWalk Robotics (NASDAQ:LFWD) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.08). ReWalk Robotics had a negative return on equity of 43.02% and a negative net margin of 77.21%. The business had revenue of $6.13 million during the quarter, compared to the consensus estimate of $8.38 million. During the same quarter last year, the firm posted ($0.56) earnings per share. On average, equities analysts forecast that ReWalk Robotics will post -1.78 earnings per share for the current year.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.